Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Hague

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesisHelena A Minter, John W Eveson, Suzanne Huntley, et al.
Oral Oncology|July 11, 2022
Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledgeGilberto Melo, Carolina Amália Barcellos Silva, Angela Hague, et al.
Experimental Cell Research|July 31, 2007
Subcellular localisation of BAG-1 and its regulation of vitamin D receptor-mediated transactivation and involucrin expression in oral keratinocytes: implications for oral carcinogenesisSan San Lee, Simon J Crabb, Nari Janghra, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactionsAdam Sharp, Simon J Crabb, Peter W M Johnson, et al.
Carcinogenesis|January 22, 2008
BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activityNadine K Clemo, Tracey J Collard, Samantha L Southern, et al.
International Journal of Cancer|July 8, 2003
The retinoblastoma protein interacts with Bag-1 in human colonic adenoma and carcinoma derived cell linesNathalie J Arhel, Graham Packham, Paul A Townsend, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesisHelena A Minter, John W Eveson, Suzanne Huntley, et al.
Oral Oncology|July 11, 2022
Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledgeGilberto Melo, Carolina Amália Barcellos Silva, Angela Hague, et al.
Experimental Cell Research|July 31, 2007
Subcellular localisation of BAG-1 and its regulation of vitamin D receptor-mediated transactivation and involucrin expression in oral keratinocytes: implications for oral carcinogenesisSan San Lee, Simon J Crabb, Nari Janghra, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactionsAdam Sharp, Simon J Crabb, Peter W M Johnson, et al.
Carcinogenesis|January 22, 2008
BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activityNadine K Clemo, Tracey J Collard, Samantha L Southern, et al.
International Journal of Cancer|July 8, 2003
The retinoblastoma protein interacts with Bag-1 in human colonic adenoma and carcinoma derived cell linesNathalie J Arhel, Graham Packham, Paul A Townsend, et al.
Pageof 2